
Chinese General Practice ›› 2024, Vol. 27 ›› Issue (26): 3304-3311.DOI: 10.12114/j.issn.1007-9572.2024.0043
Special Issue: 神经/行为/心理最新文章合辑; 脑健康最新研究合辑
• Evidence-based Medicine • Previous Articles Next Articles
Received:2024-02-10
Revised:2024-04-10
Published:2024-09-15
Online:2024-06-14
Contact:
ZHAO Chunshan
通讯作者:
赵春善
作者简介:作者贡献:
韩雪梅提出文章选题,负责研究的构思与设计,论文撰写;梅春丽、陈丹进行数据的收集与整理,统计学处理,图、表的绘制与展示;赵春善负责文章的质量控制及审校,对文章整体负责、监督管理。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2024.0043
| 步骤 | 检索式 |
|---|---|
| #1 | "Alcohols"[Mesh] |
| #2 | Ethanol OR Beer OR Wine OR Spirits OR Liquor OR drink |
| #3 | #1 OR #2 |
| #4 | "Stroke"[Mesh] |
| #5 | Cerebrovascular Accident OR Cerebrovascular Apoplexy OR Brain Vascular Accident OR Cerebrovascular Stroke OR Cerebral Infarction OR Transient Ischemic attack OR TIA |
| #6 | #4 OR #5 |
| #7 | #3 AND #6 |
Table 1 Strategy for searching eligible systematic reviews included in PubMed database
| 步骤 | 检索式 |
|---|---|
| #1 | "Alcohols"[Mesh] |
| #2 | Ethanol OR Beer OR Wine OR Spirits OR Liquor OR drink |
| #3 | #1 OR #2 |
| #4 | "Stroke"[Mesh] |
| #5 | Cerebrovascular Accident OR Cerebrovascular Apoplexy OR Brain Vascular Accident OR Cerebrovascular Stroke OR Cerebral Infarction OR Transient Ischemic attack OR TIA |
| #6 | #4 OR #5 |
| #7 | #3 AND #6 |
| 第一作者 | 发表年份(年) | 国家 | 随访年限(年) | 年龄(岁) | 性别 | 暴露人数/样本量 | 测量方法 | 摄入量范围(最低量/最高量) | 校正RR值(95%CI) | 校正因素 | NOS评分(分) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DONAHUE[ | 1986 | 美国 | 12.0 | 54.2 | 男 | 290/7 878 | 医疗记录 | 0/≥40盎司/月 | 1.50(1.10~2.20) | 因素1、因素2、因素3、尿酸、葡萄糖浓度、血红蛋白 | 8 |
| STAMPFER[ | 1988 | 美国 | 8.0 | 34~59 | 女 | 94/87 526 | 问卷调查 | 0/≥25 g/d | 0.90(0.50~1.50) | 因素1、因素2、糖尿病、绝经状态、激素使用情况、高胆固醇 | 9 |
| BERGER[ | 1999 | 美国 | 12.2 | 40~80 | 男 | 679/21 870 | 医疗记录 | <1 g/周/≥1 g/d | 0.90(0.74~1.09) | 因素1、因素2、糖尿病史 | 8 |
| LEPPALA[ | 1999 | 芬兰 | 6.1 | 50~69 | 男 | 960/26 556 | 问卷调查 | 0/>60 g/d | 1.52(1.12~2.08) | 因素1、因素2、高胆固醇血症、糖尿病、心血管病史 | 8 |
| ISO[ | 2004 | 日本 | 11.0 | 40~59 | 男 | 694/19 544 | 自我报告 | 0/≥450 g/周 | 1.43(1.05~1.96) | 因素1、因素2、糖尿病史、运动频率时间 | 8 |
| NIELSEN[ | 2005 | 丹麦 | 15.0 | >20 | 男/女 | 880/12 096 | 自我报告 | <1 g/周/>40 g/周 | 2.08(1.40~3.09) | 因素1、因素2、糖尿病、AMI病史 | 9 |
| BAZZANO[ | 2007 | 中国 | 8.0 | >40 | 男 | 3 434/64 338 | 自我报告 | 0/≥35 g/周 | 1.22(1.08~1.37) | 因素1、居住地区、糖尿病史 | 7 |
| LU[ | 2008 | 瑞典 | 11.4 | 30~50 | 女 | 170/45 449 | 自我报告 | 0/≥70 g/周 | 0.70(0.40~1.20) | 因素1、因素2、因素3、初产年龄 | 9 |
| BOS[ | 2010 | 欧洲 | 14.2 | 49~70 | 女 | 254/10 530 | 问卷调查 | 0/≥140 g/周 | 0.81(0.51~1.29) | 因素1、因素2、糖尿病、高胆固醇血症、绝经状态、每日能量摄入 | 9 |
| HIGASHIYAMA[ | 2011 | 日本 | 12.5 | 30~79 | 男 | 54/1 169 | 自我报告 | 0/≥4.0 g/周 | 0.70(0.29~1.69) | 因素1、因素2、糖尿病、高胆固醇血症、三酰甘油 | 8 |
| HIGASHIYAMA[ | 2011 | 日本 | 12.5 | 30~79 | 男 | 59/1 167 | 自我报告 | 0/≥4.0 g/周 | 4.68(1.07~20.54) | 因素1、因素2、糖尿病、高胆固醇血症、三酰甘油 | 8 |
| JIMENEZ[ | 2012 | 美国 | 26.0 | 30~55 | 女 | 2 171/83 578 | 自我报告 | 0/30~45 g/d | 1.06(0.86~1.30) | 因素1、婚姻状况、心脏病史、绝经状态、激素治疗、高胆固醇、糖尿病史 | 9 |
| IKEHARA[ | 2013 | 日本 | 16.7 | 40~69 | 女 | 1 846/47 100 | 医疗记录 | 0/≥300 g/周 | 2.30(1.52~3.49) | 因素1、因素2、糖尿病史、精神感知压力、蔬菜、鱼、水果摄入量 | 8 |
| FALKSTEDT[ | 2017 | 瑞典 | 39.0 | >18 | 男 | 1 037/49 321 | 医疗记录 | 0/>250 g/周 | 1.39(0.91~2.13) | 因素1、因素2、心血管病、家族史、糖尿病、偏头痛、心肺健康 | 7 |
| DEGERUD[ | 2021 | 挪威 | 9.1 | 19~89 | 男/女 | 547/44 476 | 医疗记录 | 2.00 g/d/59.99 g/d | 1.04(0.84~1.28) | 因素1、因素2、因素3、冠心病家族史 | 9 |
| LU[ | 2021 | 中国 | 27.0 | >18 | 男 | 352/3 906 | 医疗记录 | 0/≥36 g/d | 0.72(0.43~1.21) | 因素1、因素2、因素3 | 8 |
| LIU[ | 2023 | 中国 | 3.8 | 30~79 | 男/女 | 310/22 091 | 医疗记录 | 0/≥36 g/d | 1.34(0.82~2.19) | 因素1、因素2、糖尿病、低脂血症、蔬菜、水果、红肉摄入量 | 9 |
Table 2 Basic features of included studies
| 第一作者 | 发表年份(年) | 国家 | 随访年限(年) | 年龄(岁) | 性别 | 暴露人数/样本量 | 测量方法 | 摄入量范围(最低量/最高量) | 校正RR值(95%CI) | 校正因素 | NOS评分(分) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DONAHUE[ | 1986 | 美国 | 12.0 | 54.2 | 男 | 290/7 878 | 医疗记录 | 0/≥40盎司/月 | 1.50(1.10~2.20) | 因素1、因素2、因素3、尿酸、葡萄糖浓度、血红蛋白 | 8 |
| STAMPFER[ | 1988 | 美国 | 8.0 | 34~59 | 女 | 94/87 526 | 问卷调查 | 0/≥25 g/d | 0.90(0.50~1.50) | 因素1、因素2、糖尿病、绝经状态、激素使用情况、高胆固醇 | 9 |
| BERGER[ | 1999 | 美国 | 12.2 | 40~80 | 男 | 679/21 870 | 医疗记录 | <1 g/周/≥1 g/d | 0.90(0.74~1.09) | 因素1、因素2、糖尿病史 | 8 |
| LEPPALA[ | 1999 | 芬兰 | 6.1 | 50~69 | 男 | 960/26 556 | 问卷调查 | 0/>60 g/d | 1.52(1.12~2.08) | 因素1、因素2、高胆固醇血症、糖尿病、心血管病史 | 8 |
| ISO[ | 2004 | 日本 | 11.0 | 40~59 | 男 | 694/19 544 | 自我报告 | 0/≥450 g/周 | 1.43(1.05~1.96) | 因素1、因素2、糖尿病史、运动频率时间 | 8 |
| NIELSEN[ | 2005 | 丹麦 | 15.0 | >20 | 男/女 | 880/12 096 | 自我报告 | <1 g/周/>40 g/周 | 2.08(1.40~3.09) | 因素1、因素2、糖尿病、AMI病史 | 9 |
| BAZZANO[ | 2007 | 中国 | 8.0 | >40 | 男 | 3 434/64 338 | 自我报告 | 0/≥35 g/周 | 1.22(1.08~1.37) | 因素1、居住地区、糖尿病史 | 7 |
| LU[ | 2008 | 瑞典 | 11.4 | 30~50 | 女 | 170/45 449 | 自我报告 | 0/≥70 g/周 | 0.70(0.40~1.20) | 因素1、因素2、因素3、初产年龄 | 9 |
| BOS[ | 2010 | 欧洲 | 14.2 | 49~70 | 女 | 254/10 530 | 问卷调查 | 0/≥140 g/周 | 0.81(0.51~1.29) | 因素1、因素2、糖尿病、高胆固醇血症、绝经状态、每日能量摄入 | 9 |
| HIGASHIYAMA[ | 2011 | 日本 | 12.5 | 30~79 | 男 | 54/1 169 | 自我报告 | 0/≥4.0 g/周 | 0.70(0.29~1.69) | 因素1、因素2、糖尿病、高胆固醇血症、三酰甘油 | 8 |
| HIGASHIYAMA[ | 2011 | 日本 | 12.5 | 30~79 | 男 | 59/1 167 | 自我报告 | 0/≥4.0 g/周 | 4.68(1.07~20.54) | 因素1、因素2、糖尿病、高胆固醇血症、三酰甘油 | 8 |
| JIMENEZ[ | 2012 | 美国 | 26.0 | 30~55 | 女 | 2 171/83 578 | 自我报告 | 0/30~45 g/d | 1.06(0.86~1.30) | 因素1、婚姻状况、心脏病史、绝经状态、激素治疗、高胆固醇、糖尿病史 | 9 |
| IKEHARA[ | 2013 | 日本 | 16.7 | 40~69 | 女 | 1 846/47 100 | 医疗记录 | 0/≥300 g/周 | 2.30(1.52~3.49) | 因素1、因素2、糖尿病史、精神感知压力、蔬菜、鱼、水果摄入量 | 8 |
| FALKSTEDT[ | 2017 | 瑞典 | 39.0 | >18 | 男 | 1 037/49 321 | 医疗记录 | 0/>250 g/周 | 1.39(0.91~2.13) | 因素1、因素2、心血管病、家族史、糖尿病、偏头痛、心肺健康 | 7 |
| DEGERUD[ | 2021 | 挪威 | 9.1 | 19~89 | 男/女 | 547/44 476 | 医疗记录 | 2.00 g/d/59.99 g/d | 1.04(0.84~1.28) | 因素1、因素2、因素3、冠心病家族史 | 9 |
| LU[ | 2021 | 中国 | 27.0 | >18 | 男 | 352/3 906 | 医疗记录 | 0/≥36 g/d | 0.72(0.43~1.21) | 因素1、因素2、因素3 | 8 |
| LIU[ | 2023 | 中国 | 3.8 | 30~79 | 男/女 | 310/22 091 | 医疗记录 | 0/≥36 g/d | 1.34(0.82~2.19) | 因素1、因素2、糖尿病、低脂血症、蔬菜、水果、红肉摄入量 | 9 |
| [1] |
王陇德,彭斌,张鸿祺,等. 《中国脑卒中防治报告2020》概要[J]. 中国脑血管病杂志,2022,19(2):136-144.
|
| [2] |
|
| [3] |
|
| [4] |
江滨. 现阶段我国脑卒中流行特征及防治现状对全科医疗服务的启示和建议[J]. 中国全科医学,2019,22(30):3653-3661. DOI:10.12114/j.issn.1007-9572.2019.00.445.
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
罗美玲,林希建,刘如春,等. 剂量反应关系Meta分析在Stata软件中的实现[J]. 循证医学,2014,14(3):182-187. DOI:10.3969/j.issn.1671-5144.2014.03.012.
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国脑血管病一级预防指南2019[J]. 中华神经科杂志,2019,52(9):684-709. DOI:10.3760/cma.j.issn.1006-7876.2019.09.002.
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [1] | DU Huijie, YANG Xuezhi, LIU Zuting, LIU Xingyu, ZHANG Huiqin, LUO Tian, YANG Xia, LIU Song, KUANG Jie. One-year Recurrence Risk Prediction in Large Artery Atherosclerotic Acute Ischemic Stroke Using Random Survival Forest [J]. Chinese General Practice, 2026, 29(31): 4619-4626. |
| [2] | GUO Zhihong, CHEN Yingying, LIU Dewu. Efficacy and Safety of Antibiotic Bone Cement Combined with Vacuum Sealing Drainage for Diabetic Foot: a Meta-analysis [J]. Chinese General Practice, 2026, 29(30): 4503-4512. |
| [3] | ZHAO Congjuan, JIN Tiantian, LIANG Jie, WANG Beining, GAO Yan. Comparative Effectiveness of GLP-1 Receptor Agonists on Patients with Diabetic Kidney Disease: a Network Meta-analysis [J]. Chinese General Practice, 2026, 29(29): 4326-4336. |
| [4] | ZHAN Daowei, WEI Xuwang, HU Minlei, XU Yingmei, YANG Xibing, LUO Kaitao. Effect of Acupuncture Combined with Tirofiban on Early Neurological Deterioration in Patients with Ischemic Stroke after Thrombolysis: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(29): 4241-4247. |
| [5] | JIANG Yanlin, WANG Zhe, ZHAI Rui, ZHANG Mengjie, CHEN Xi, WANG Junhong. Screening Optimal Traditional Chinese Medicine Compound Formulas for ADHD Treatment: a Study Integrating Network Meta-analysis and Entropy-weighted TOPSIS Method [J]. Chinese General Practice, 2026, 29(27): 3985-3994. |
| [6] | SHANG Ying, WANG Fei, HUANG Yaqi, MA Xiaoning, ZHANG Shengfu, XU Nenggui, GUO Bin. Shaoyao Gancao Decoction Combined with Electroacupuncture Improves Synaptic Plasticity in Poststroke Spastic Rats [J]. Chinese General Practice, 2026, 29(26): 3798-3804. |
| [7] | LIN Yansheng, ZHANG Shuyang, LIN Jiaying, ZHU Jie, ZHOU Yuxin, LIN Jiali, JIA Jie. Correlation of Upper Limb Somatosensory Function and Attention, and Memory in Stroke Patients with Different Sides of Hemiplegia [J]. Chinese General Practice, 2026, 29(26): 3752-3759. |
| [8] | ZHUANG Mingnan, YAN Henghao, XIAO Ningkun, YIN Mingyue, FAN Zhiwei, LIU Chaohui, ZOU Xintong, ZHOU Yuehua, BI Zhiyuan, DENG Hengzhi, WU Bitai, SONG Zhiquan, SHI Donglin. Effects of Interval and Continuous Training on Cognitive Function in Healthy Adults: a Systematic Review and Three-level Meta-analysis [J]. Chinese General Practice, 2026, 29(26): 3816-3828. |
| [9] | LI Xueni, LIU Gejing, LIU Yongming. Efficacy and Safety of Semaglutide in Patients with Heart Failure: a Meta-Analysis [J]. Chinese General Practice, 2026, 29(24): 3509-3519. |
| [10] | WANG Rui, LUO Shuoming, YANG Liang, WANG Peng, ZHAO Yang, WANG Qi, ZHOU Zhiguang. Diabetes Prevalence among Older Adults in China: a Systematic Review and Meta-analysis [J]. Chinese General Practice, 2026, 29(24): 3500-3508. |
| [11] | PEI Ruqing, ZHOU Yuqiu, ZHANG Siyu, LIU Xijun. Meta-analysis of Influencing Factors of Relapse in Chinese Patients with Schizophrenia [J]. Chinese General Practice, 2026, 29(23): 3359-3370. |
| [12] | JI Changmeng, XU Sihui, LI Tianhu, DING Yong, WANG Weiqiang. Efficacy of Low-frequency Repetitive Transcranial Magnetic Stimulation Combined with Transcutaneous Electrical Acupoint Stimulation for the Treatment of Upper Limb Motor Impairment in Post-stroke Patients: a Randomized Controlled Trial [J]. Chinese General Practice, 2026, 29(23): 3275-3280. |
| [13] | GE Dan, WANG Zhi, DING Qun, GUO Tonglan, XU Tongdao. Relationship between Remnant Cholesterol and Non-alcoholic Fatty Liver Disease as well as Progressive Liver Fibrosis in Patients with Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2026, 29(20): 2854-2859. |
| [14] | YANG Xiaofeng, LI Xianwen, WU Yanfeng, ZHANG Qian, CHEN Juan, ZHAO Fengjiao. Association of Serum Vascular Endothelial Cadherin Levels with the Risk of Post-stroke Cognitive Impairment in Patients with Acute Ischemic Stroke [J]. Chinese General Practice, 2026, 29(20): 2867-2873. |
| [15] | LIU Ying, LIU Shiwei, ZHANG Chi, SHEN Ji, ZHANG Yushan, ZHANG Jie, SANG Yingchen, WANG Youjiao, WANG Lei, ZHOU Houguang, SHI Hong. Prevalence and Associated Factors of Subjective Cognitive Decline among Older Stroke Patients in China [J]. Chinese General Practice, 2026, 29(20): 2829-2835. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||